REVENUES (Details 2) - Customer Concentration Risk [Member] |
12 Months Ended | |
---|---|---|
Dec. 31, 2019 |
Dec. 31, 2018 |
|
AmerisourceBergen Specialty Group [Member] | ||
Entity Wide Revenue Major Customer [Line Items] | ||
Concentration risk, percentage | 58.00% | 78.00% |
McKesson Plasma and Biologics LLC [Member] | ||
Entity Wide Revenue Major Customer [Line Items] | ||
Concentration risk, percentage | 23.00% | 14.00% |
Accounts Receivables [Member] | AmerisourceBergen Specialty Group [Member] | ||
Entity Wide Revenue Major Customer [Line Items] | ||
Concentration risk, percentage | 56.00% | 57.00% |
Accounts Receivables [Member] | McKesson Plasma and Biologics LLC [Member] | ||
Entity Wide Revenue Major Customer [Line Items] | ||
Concentration risk, percentage | 31.00% | 25.00% |
X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|